Albuterol (as sulfate) 0.5%. By nebulizer: 2.5mg (0.5mL of 0.5% diluted to 3mL with sterile normal saline, or 3mL of 0.083%) 3–4 times daily. Avoid excessive use. Sensitivity to sympathomimetics.

In children with significant respiratory distress, we initiate a dose of either 75 mg/hr (half diluted 5 mg/mL) albuterol solution delivered via a HEART nebulizer (High-output Extended Aerosol ...

Albuterol (as sulfate) 0.63mg/3mL (0.021%), 1.25mg/3mL (0.042%); preservative-free. Avoid excessive use. Sensitivity to sympathomimetics. Consider higher dose albuterol product in acute attack ...

The albuterol nebulizer solution, 2.5 to 5 mg, depending on severity, can be used via a compressed air driven nebulizer. The 2.5 mg dose of the nebulizer solution delivers a dose approximately ...

The Primatene Mist inhaler is the only over-the-counter (OTC) asthma inhaler approved by the FDA for the relief of asthma symptoms including wheezing, chest tightness, and shortness of breath in ...

This leaflet answers some common questions about Atrovent Inhalation Solution. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

How to use a nebulizer. We're going to set up the compressor nebulizer. You need an air compressor, many of them are electrically powered. There are a couple out on the market that are battery ...

The NE-U22V MicroAir®, the world’s smallest nebulizer utilizing Vibrating Mesh Technology (V.M.T.), efficiently delivers solution medications for patients suffering from asthma, COPD or other ...

CRN‘s Solution Provider 500 ranks the top integrators, service providers and IT consultants in North America by services revenue. CRN breaks out which solution providers in each U.S. state and ...

The U.S. surgeon general’s call for mandatory, tobacco-style warnings on social media to raise awareness about its association with “significant mental health harms” is an important ...

Our lead program, molgramostim inhalation solution, is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar ...